These data demonstrated that CST1 and GPX4 participate in the malignant progression of GC, and serological detection of CST1 in GC patients provides a strong diagnostic basis for the diagnosis, recurrence, and metastasis detection of GC patients. The gene discussed is GPX4; the disease is gastric cancer.